Relay Therapeutics Inc <RLAY.O>: Canaccord Genuity initiates coverage with buy rating; price target $29
RLAY•Related News
Xometry Inc <XMTR.O>: Wedbush assumes coverage with outperform rating; target price $126
XMTR•
FDA Approves Merck's LIPFENDRA Tablets To Reduce Cholesterol In Adults
MRK•
Nasdaq Trade Halt <NVVE.O> Volatility Trading Pause at 09:33 AM
NVVE•
Amex halt <ASTT.A> add info lst 23.858000
ASTT•
Trump Media unveils data feed for businesses tracking Truth Social posts
DJT•